2) chronic active hepatitis B
慢性活动性乙型肝炎
1.
Methods Contents of serum HBV DNA and LN,HA,PⅢ,Ⅳ C in 30 patients with chronic active hepatitis B before treatment and 3,6,9 months after Lamivudine treatment were determined by PCR?Flourescence quantity and competitive radioimmunoassay respectively.
方法 对 30例慢性活动性乙型肝炎患者治疗前和拉米夫定治疗 3、6、9个月后的血清 ,分别采用荧光全定量PCR法测定HBVDNA浓度和竞争性放射免疫法测定层粘连蛋白(LN)、透明质酸 (HA)、Ⅲ型前胶原 (PⅢ )、Ⅳ型胶原 (ⅣC)水平并进行比较。
3) chronic active hepatitis (CAH)
慢性活动型肝炎
4) the active hepatitis
活动性肝炎
1.
The curative observation of Lamivudine in treatment of the active hepatitis and hepatocirrhosis
拉米夫定治疗活动性肝炎肝硬化疗效观察
5) hepatitis B reactivation
乙型肝炎再激活
1.
Objective:To investigate the turnover of hepatic tissue pathology,hepatitis B reactivation rate in chronic HBV carriers.
目的:了解慢性乙型肝炎病毒携带者的肝组织病理改变、乙型肝炎再激活率等。
6) Chronic active hepatitis
慢性活动性肝炎
1.
Objective:To study the effects of Ying gan fu kang (GFK) on experimental chronic active hepatitis in mice.
目的 研究硬肝复康对实验性慢性活动性肝炎的防治作用。
2.
Methods The nucleotide sequences of X and precore/core genes of serum HBV were cloned and sequenced in 14 asymptomatic carriers (AsCs) and 14 chronic active hepatitis (CAH) patients with antibody against hepatitis B e antigen.
方法 对e抗体阳性14例无症状携带（AsC）者及e抗体阳性14例慢性活动性肝炎（CAH）患者的血清HBV X及前C/C基因序列进行克隆、测序。
3.
The effects of Yingganfukang(GFK)on experimental chronic active hepatitis in mice were studied.
目的:研究硬肝复康对实验性慢性活动性肝炎的防治作用。
补充资料：慢性活动性乙型肝炎
慢性活动性乙型肝炎
chronic active hepaititis B
病程超过半年，各项症状(消化道症状如厌食、恶心、呕吐、腹胀、腹泻等；神经症状如乏力、萎靡、头晕、失眠等及肝区痛）明显，肝肿大，质地中等以上，可伴有蜘蛛痣、肝掌、毛细血管扩张或肝病面容，进行性脾肿大，肝功能持续异常，或伴有肝外器官损害，或免疫球蛋白、自身抗体持续升高等特征。病理改变以门脉区周围最为明显，门脉区有大量淋巴细胞、浆细胞及巨噬细胞浸润因而扩大。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条